HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 194 filers reported holding HERON THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $3,000 | -25.0% | 200 | 0.0% | 0.00% | – |
| Q4 2020 | $4,000 | +33.3% | 200 | 0.0% | 0.00% | – |
| Q3 2020 | $3,000 | -25.0% | 200 | -25.4% | 0.00% | – |
| Q2 2020 | $4,000 | 0.0% | 268 | 0.0% | 0.00% | – |
| Q1 2020 | $4,000 | -33.3% | 268 | 0.0% | 0.00% | -100.0% |
| Q4 2019 | $6,000 | -33.3% | 268 | -42.7% | 0.00% | 0.0% |
| Q3 2019 | $9,000 | +12.5% | 468 | +4.0% | 0.00% | 0.0% |
| Q2 2019 | $8,000 | -27.3% | 450 | +1.1% | 0.00% | 0.0% |
| Q1 2019 | $11,000 | +120.0% | 445 | +122.5% | 0.00% | 0.0% |
| Q4 2018 | $5,000 | -16.7% | 200 | -3.4% | 0.00% | 0.0% |
| Q3 2018 | $6,000 | -25.0% | 207 | +3.5% | 0.00% | 0.0% |
| Q2 2018 | $8,000 | +33.3% | 200 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $6,000 | +50.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $4,000 | +33.3% | 200 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $3,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $1,900 | 100.00% |
| Velan Capital Investment Management LP | 2,500,000 | $6,250,000 | 5.52% |
| GREAT POINT PARTNERS LLC | 6,360,161 | $15,900,403 | 3.12% |
| Cheyne Capital Management (UK) LLP | 318,008 | $795,020 | 1.39% |
| TANG CAPITAL MANAGEMENT LLC | 3,755,934 | $9,389,835 | 1.36% |
| Rubric Capital Management LP | 11,750,000 | $29,375,000 | 1.28% |
| Orchard Capital Management, LLC | 1,391,080 | $3,477,700 | 1.17% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 267,028 | $667,570 | 0.81% |
| CM Management, LLC | 250,000 | $625 | 0.75% |
| Tejara Capital Ltd | 493,619 | $1,234,048 | 0.71% |